Tech Company Financing Transactions
Alcresta Therapeutics Funding Round
On 3/31/2016, Alcresta Therapeutics raised $6 million in funding from Bessemer Venture Partners and Frazier Healthcare Partners.
Transaction Overview
Company Name
Announced On
3/31/2016
Transaction Type
Venture Equity
Amount
$5,999,000
Round
Undisclosed
Investors
Bessemer Venture Partners (Stephen Kraus)
Frazier Healthcare Partners (James Topper)
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
1 Newton Executive Park 100
Newton, MA 02462
USA
Newton, MA 02462
USA
Phone
Website
Email Address
Overview
Alcresta's enzyme expertise and proprietary platform enables novel products for those with compromised pancreatic output and malabsorption.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Daniel Orlando
Chief Financial Officer
Tasos Konidaris
Chief Scientific Officer
Eric First
VP - General Counsel
William Scheinler
VP - Sales
Darbi James
Browse more venture capital transactions:
Prev: 3/31/2016: PlayBuzz venture capital transaction
Next: 3/31/2016: Impact Health venture capital transaction
Share this article
About Our VC Transactions Data
We record every notable VC transaction. All VC database entries on this site are derived from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs